Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

NJR

Amy B. Mansue Joins New Jersey Resources Corp Board

New Jersey Resources (NYSE: NJR) recently announced the election of Amy B. Mansue to its board of directors, effective November 1, 2025. Mansue, who currently serves as President and CEO of Inspira Health Network, brings extensive experience from the public and private sectors to her new role.

Prior to her current position, Mansue held leadership roles at RWJBarnabas Health and Children's Specialized Hospital. She also has a background in the public sector, having worked for Congressman James J. Florio and serving in various roles in the New Jersey state government.

Mansue's addition to the board is expected to bring valuable insight to New Jersey Resources as it continues to position itself for long-term value for both shareholders and customers.

New Jersey Resources, a Fortune 1000 company, operates through its subsidiaries to provide natural gas and clean energy services. Its principal subsidiary, New Jersey Natural Gas, serves customers in several New Jersey counties. The company also has Clean Energy Ventures, Energy Services, Storage and Transportation, and Home Services divisions.

With over 1,300 employees, New Jersey Resources is committed to promoting energy conservation and efficiency through initiatives such as Conserve to Preserve® and SaveGreen®.

The specific details of the company's financial performance were not mentioned in the press release. The market has reacted to these announcements by moving the company's shares 0.77% to a price of $47.23. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS